Marton Laurence 4
4 · RenovoRx, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Marton Laurence
Director
Transactions
- Purchase
Common Stock
2025-04-08$0.85/sh+12,050$10,218→ 45,684 total
Footnotes (1)
- [F1]Reflects an open market purchase of the Issuer's securities.